Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by dardanion Aug 24, 2016 12:18pm
319 Views
Post# 25172176

RE:RE:What would someone pay 14c this morning?

RE:RE:What would someone pay 14c this morning?What some people are missing is that it is a binding agreement at 14 cents subject to a shareholder vote. The odds are low you'll lose anything by taking a position at 14 cents since that sp is guaranteed by PLI and the offer is backed by the TST BOD. If another offer comes for a few pennies more fine but shareholders wouldn't vote to return to a 7 cent share price. Insulting really how the same BOD whose leadership is responsible for the sp collapse now considers the offer to have a good premium for long shareholders who will lose heavily on this deal.

Commenting on this announcement, Mr. James Rae, Chairman of the Board of Directors of Telesta Therapeutics stated: "Following a very comprehensive review of multiple strategic options, Telesta's Board of Directors has unanimously endorsed the recommendation of the Special Committee of the Board of Directors to recommend to shareholders the acceptance of this purchase offer from ProMetic Life Sciences. This offer represents a significant premium to Telesta's share price since February, 2016.  ProMetic Life Sciences is uniquely positioned to leverage Telesta's financial, manufacturing and human resources, while delivering to Telesta shareholders, through this payment in ProMetic shares, significant potential future upside as they bring their large therapeutic pipeline to commercial deployment."
<< Previous
Bullboard Posts
Next >>